The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
NCT04475107 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 113
Last updated 2021-06-01
Summary
This study is a multi-center, randomized, double-blind, parallel, placebo-controlled, phase Ⅱ clinical trial to evaluate efficacy and safety of Pyramax in mild to moderate COVID-19 patients.
Conditions
Interventions
- DRUG
-
Pyronaridine-Artesunate
Pyramax
- DRUG
-
Placebo
Sponsors & Collaborators
-
Shin Poong Pharmaceutical Co. Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-09
- Primary Completion
- 2021-03-25
- Completion
- 2021-04-15
Countries
- South Korea
Study Locations
More Related Trials
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection
NCT03376321 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
NCT04547140 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
NCT00419263 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
NCT00958776 ·Status: TERMINATED ·Phase: PHASE3
-
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
NCT04515147 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
NCT01224795 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza
NCT02635724 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)
NCT04383574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19
NCT04709835 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
NCT05352347 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Intranasal INNA-051 for Prevention of COVID-19 in Adults
NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
NCT07157007 ·Status: RECRUITING ·Phase: PHASE2
-
Favipiravir Therapy in Adults With Mild COVID-19
NCT04464408 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19
NCT07089680 ·Status: NOT_YET_RECRUITING
-
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza
NCT00640874 ·Status: WITHDRAWN
-
Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males
NCT01428479 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
NCT04425460 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3
-
A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2
NCT05765279 ·Status: COMPLETED ·Phase: NA
-
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
NCT04561219 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia
NCT04679350 ·Status: TERMINATED ·Phase: PHASE2